Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2013 3
2018 1
2020 1
2022 1
2024 3
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
Therapeutic potential of co-signaling receptor modulation in hepatitis B.
Andreata F, Laura C, Ravà M, Krueger CC, Ficht X, Kawashima K, Beccaria CG, Moalli F, Partini B, Fumagalli V, Nosetto G, Di Lucia P, Montali I, Garcia-Manteiga JM, Bono EB, Giustini L, Perucchini C, Venzin V, Ranucci S, Inverso D, De Giovanni M, Genua M, Ostuni R, Lugli E, Isogawa M, Ferrari C, Boni C, Fisicaro P, Guidotti LG, Iannacone M. Andreata F, et al. Among authors: venzin v. Cell. 2024 Jul 25;187(15):4078-4094.e21. doi: 10.1016/j.cell.2024.05.038. Epub 2024 Jun 18. Cell. 2024. PMID: 38897196 Free PMC article.
Intrahepatic immunity to hepatitis B virus.
Venzin V, Beccaria CG, Andreata F, Fumagalli V, Iannacone M. Venzin V, et al. J Hepatol. 2024 Nov;81(5):911-913. doi: 10.1016/j.jhep.2024.05.029. Epub 2024 Jul 30. J Hepatol. 2024. PMID: 39079776 No abstract available.
CD4+ T cells license Kupffer cells to reverse CD8+ T cell dysfunction induced by hepatocellular priming.
Venzin V, Beccaria CG, Perucchini C, Delfino P, Bono EB, Giustini L, Moalli F, Grillo M, Fumagalli V, Laura C, Di Lucia P, Reinhard K, Petschenka J, Omokoko TA, Celant A, Ottolini S, Kawashima K, Ravà M, De Giovanni M, Inverso D, Kuka M, Kennedy PTF, Guilliams M, Casorati G, Pedica F, Ponzoni M, Şahin U, Le Bert N, Bertoletti A, Vascotto F, Guidotti LG, Iannacone M. Venzin V, et al. Nat Immunol. 2025 Aug;26(8):1352-1366. doi: 10.1038/s41590-025-02199-3. Epub 2025 Jun 30. Nat Immunol. 2025. PMID: 40588520 Free PMC article.
Highlights from the 2023 International Meeting on the Molecular Biology of Hepatitis B virus.
HBV2023; Allweiss L, Cohen C, Dias J, Fumagalli V, Guo H, Harris JM, Hu J, Iannacone M, Isogawa M, Jeng WJ, Kim KH, Kramvis A, Li W, Lucifora J, Muramatsu M, Neuveut C, Ploss A, Pollicino T, Protzer U, Tan A, Tanaka Y, Tu T, Tsukuda S, Thimme R, Urban S, Watashi K, Yuan Z, Yeh SH, McKeating JA, Revill PA. HBV2023, et al. J Gen Virol. 2024 May;105(5):001978. doi: 10.1099/jgv.0.001978. J Gen Virol. 2024. PMID: 38757942 Free PMC article. Review.
Group 1 ILCs regulate T cell-mediated liver immunopathology by controlling local IL-2 availability.
Fumagalli V, Venzin V, Di Lucia P, Moalli F, Ficht X, Ambrosi G, Giustini L, Andreata F, Grillo M, Magini D, Ravà M, Friedrich C, Fontenot JD, Bousso P, Gilmore SA, Khan S, Baca M, Vivier E, Gasteiger G, Kuka M, Guidotti LG, Iannacone M. Fumagalli V, et al. Among authors: venzin v. Sci Immunol. 2022 Feb 25;7(68):eabi6112. doi: 10.1126/sciimmunol.abi6112. Epub 2022 Feb 25. Sci Immunol. 2022. PMID: 35213210
12 results